M. M. Kamil, M. A.-. H. Jabarah, and N. A.l. Jasim, “Immunogenicity of the biosimilar CT-P13 infliximab or the original infliximab in Iraqi patients with Ankylosing spondylitis does not correlate with their demographic characteristics”, JFacMedBagdad, vol. 64, no. 4, pp. 261–267, Jan. 2023, doi: 10.32007/jfacmedbagdad.6441969.